Differential Androgen Deprivation Therapies with Anti-androgens Casodex/Bicalutamide or MDV3100/Enzalutamide versus Anti-androgen Receptor ASC-J9® Lead to Promotion versus Suppression of Prostate Cancer Metastasis-Reference-Cited by-同舟云学术

Differential Androgen Deprivation Therapies with Anti-androgens Casodex/Bicalutamide or MDV3100/Enzalutamide versus Anti-androgen Receptor ASC-J9® Lead to Promotion versus Suppression of Prostate Cancer Metastasis

Published:2013-07 Issue:27 Volume:288 Page:19359-19369
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Lin Tzu-Hua,Lee Soo Ok,Niu Yuanjie,Xu Defeng,Liang Liang,Li Lei,Yeh Shauh-Der,Fujimoto Naohiro,Yeh Shuyuan,Chang Chawnshang

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference43 articles.

1. Androgen deprivation therapy for prostate cancer. Current status and future prospects;Miyamoto;Prostate,2004

2. Abiraterone and increased survival in metastatic prostate cancer;de Bono;N. Engl. J. Med,2011

3. Antitumour activity of MDV3100 in castration-resistant prostate cancer. A phase 1–2 study;Scher;Lancet,2010

4. Survival following primary androgen deprivation therapy among men with localized prostate cancer;Lu-Yao;JAMA,2008

5. Androgen receptor is a tumor suppressor and proliferator in prostate cancer;Niu;Proc. Natl. Acad. Sci. U.S.A,2008

Cited by 106 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of Drug Sensitisers to Improve Therapeutic Index in Cancer;Pharmaceutics;2024-07-11

2. The correlation between TRIM28 expression and immune checkpoints in CRPC;The FASEB Journal;2024-07-03

3. Synthesis of curcumin derivatives targeting androgen receptor for castration‐resistant prostate cancer therapy;Chemical Biology & Drug Design;2024-07

4. Therapeutic implications of signaling pathways and tumor microenvironment interactions in esophageal cancer;Biomedicine & Pharmacotherapy;2024-07

5. Knocking down AR promotes osteoblasts to recruit prostate cancer cells by altering exosomal circ-DHPS/miR-214-3p/CCL5 pathway;Asian Journal of Andrology;2023-11-14